Category: Medical Subspecialties

A UVA Health-developed artificial pancreas system is among the nominees for 2019’s best biomedical research and is… read more >

The U.S. Food and Drug Administration has approved an artificial pancreas system – based on technology from… read more >

University of Virginia (UVA) Center for Diabetes Technology and Novo Nordisk today announced that they have entered into a five-year research collaboration where UVA and Novo Nordisk will work together on the development of virtual environments focused on modelling of patients with type 2 diabetes.

Only 8% of Americans survive cardiac arrest outside a hospital, but that percentage could increase significantly if… read more >

233 UVA Health physicians have been named by their peers to the 2019-2020 Best Doctors in America®List…. read more >

A multicenter randomized clinical trial evaluating a new artificial pancreas system — which automatically monitors and regulates blood glucose levels — has found that the new system was more effective than existing treatments at controlling blood glucose levels in people with type 1 diabetes.

A UVA Health interventional radiologist has harnessed the power of virtual reality to increase the availability of a less-invasive treatment option for thyroid patients.

The same approach that could prevent diabetes may also prove effective for battling autoimmune diseases such as lupus and eczema.

The Blue Ridge Poison Center at UVA Health joins the U.S. Centers for Disease Control and Prevention (CDC) in alerting the public to nearly 100 cases nationally of lung illnesses that appear to be linked to vaping. No deaths have been reported, but many patients have experienced life-threatening symptoms and needed emergency hospital care.

U.S. News & World Report has ranked University of Virginia Medical Center as the No. 1 hospital in Virginia for the fourth consecutive year.